Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy.
J Pediatr
; 240: 150-157.e4, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34481805
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Remission Induction
/
Gastrointestinal Agents
/
Inflammatory Bowel Diseases
/
Endoscopy, Digestive System
/
Infliximab
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Pediatr
Year:
2022
Type:
Article
Affiliation country:
Belgium